WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China's Pharma Market Faces Mixed Performance in Q1 2025 Amid Shifting Sector ... The first quarter of 2025 revealed a complex landscape for China's pharmaceutical industry, with total drug sales across public hospitals and retail pharmacies amounting ...
(6/30/2025)

Analyzing Key Trends in China's Patent-Linkage... (6/27/2025)

Fresh Antitrust Guidelines to Address Pharmace... (6/27/2025)

Breaking the Boundaries: A New Map of Physicia... (6/25/2025)

Structuring Cross Border China Biotech 'NewCo'... (6/19/2025)

CDE Annual Report Reveals Strong Growth and Ev... (6/19/2025)

China Emerges as Prime Global Target for Multi... (6/17/2025)

China Proposes Shorter Clinical Trial Reviews ... (6/16/2025)

China's AI Healthcare Market (Part II): Opport... (6/12/2025)

China's AI Healthcare Market (Part I): Growth ... (6/12/2025)

Following FDA's Elsa, China Accelerates AI Hea... (6/9/2025)

China Ascends to Global Leadership in Oncology... (6/5/2025)

Mainland Chinese Market for Weight Loss and Di... (6/5/2025)

Biological E and China's Recbio Partner ... (7/1/2025) Hutchmed Receives China NMPA Approval fo... (7/1/2025) Mabwell Announces License Deal with Qil... (7/1/2025) CDE Reopens Public Consultation on Revis... (6/30/2025) China's Draft National Medical Security ... (6/30/2025) China's Pharma Market Faces Mixed Perfor... (6/30/2025) China Medical System to Pursue Secondary... (6/30/2025) GenFleet IPO Highlights Promising RAS-Ta... (6/30/2025) QL Biopharma's Dual GLP‑1/FGF21 Agonist... (6/30/2025) Conjupro Files USPTO Challenge on Asclet... (6/30/2025) Pfizer China's Emblaveo Cleared by NMPA ... (6/30/2025) Cutia's Topical Finasteride Spray CU‑40... (6/30/2025) CTTQ's Anlotinib Wins Approval in China ... (6/30/2025) BlissBio Advances Toward IPO with Focus ... (6/30/2025) Recent Official and Executive Moves (6/28/2025) China Releases Draft Medical Security La... (6/28/2025) China Raises Per Capita Public Health Fu... (6/28/2025) Innovent Wins Landmark China Approval fo... (6/28/2025)

China's Pharma Market Faces Mixed Performance in Q1 202... China's Retail Pharmacy Market Hits CNY 941.1B in 2024 ... NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co...

Mabwell Announces License Deal with Qilu for Albipagra... Hutchmed Receives China NMPA Approval for Lung Cancer D... Biological E and China's Recbio Partner to Bring HPV9 V... BlissBio Advances Toward IPO with Focus on Next-Generat... GenFleet IPO Highlights Promising RAS-Targeted Drug Pip...

CDE Reopens Public Consultation on Revised Technical Gu... CDE Issues the Technical Guidelines for IVRT and IVPT o... CDE Solicits Comments on the Draft ICH Guideline E21:... CDE Solicits Comments on the Draft ICH Guideline E21: ... CDE Solicits Comments on the Draft Technical Guidelines...

China Raises Per Capita Public Health Funding to Suppor... China Issues Guidelines to Promote TCM and Western Medi... China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem... China's Child Health Improves: NHC Official

Conjupro Files USPTO Challenge on Ascletis' U.S. Patent... China's Draft National Medical Security Law: Seven Key ... China Releases Draft Medical Security Law for Public Co... Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Sche... Gavi Launches $224M Arbitration Claim Against Clover Bi...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

CTTQ's Anlotinib Wins Approval in China for First-Line ... Cutia's Topical Finasteride Spray CU‑40102 Approved in... Pfizer China's Emblaveo Cleared by NMPA for Tough Gram... QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains ... I-Mab Unveils Encouraging Givastomig Results in First-L...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...